Development and Validation of the SDLD-Score: a Simplified Tool to Predict Successful Endoscopic Papillectomy in Ampullary Lesions. Academic Article uri icon

Overview

abstract

  • BACKGROUND AND STUDY AIMS: Endoscopic papillectomy (EP) is the standard treatment for non-invasive ampullary lesions (AL), while advanced cases require surgery. Managing AL is challenging and may lead to over- or undertreatment. We developed a score to identify the best candidates for endoscopic or surgical treatment. PATIENTS AND METHODS: We analyzed 447 patients who underwent EP. The cohort was randomly split into a training (n=325) and validation set (n=122). Logistic regression identified predictors for incomplete resection (R1), which were incorporated into a four-item score. Performance was assessed using AUROC. RESULTS: Independent predictors for R1 included size≥30mm(S), high-grade dysplasia/invasive cancer(D), laterally-spreading-lesion(L), and bile/pancreatic duct dilation(D). AL with 0-1 points had the highest R0 rates (training: 86.0%; validation: 88.5%), while ≥2 points significantly increased R1 rates (training: 52.0%; validation: 57.7%; p<0.001). AUROC was 0.792 (training) and 0.708 (validation). CONCLUSION: The SDLD score predicts incomplete resection in EP and aids treatment decisions.

authors

  • Trung, Kien Vu
  • Abou-Ali, Einas
  • Gulla, Aiste
  • Soares, Kevin
  • Caillol, Fabrice
  • Paik, Woo H
  • Napoleon, Bertrand
  • Halimi, Asif
  • Masaryk, Viliam
  • Bruno, Marco J
  • Pérez-Cuadrado-Robles, Enrique
  • Bolm, Louisa
  • Seyfried, Steffen
  • Petrone, Maria C
  • Yilmaz, Bengisu
  • Vollmer, Charles
  • Berger, Arthur
  • Maggino, Laura
  • Schemmer, Peter
  • Wichmann, Dörte
  • Karam, Elias
  • Dugic, Ana
  • Kunovsky, Lumir
  • Regner, Sara
  • Gaujoux, Sebastien
  • Hollenbach, Marcus

publication date

  • May 29, 2025

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.gie.2025.03.1333

PubMed ID

  • 40449630